144 related articles for article (PubMed ID: 10796791)
21. Effect of cisplatin-based neoadjuvant chemotherapy on survival in patients with bladder cancer: a meta-analysis.
Li G; Niu HM; Wu HT; Lei BY; Wang XH; Guo XB; Feng SL
Clin Invest Med; 2017 Apr; 40(2):E81-E94. PubMed ID: 28447581
[TBL] [Abstract][Full Text] [Related]
22. Neoadjuvant chemotherapy for bladder cancer.
Sonpavde G; Lerner SP
Oncology (Williston Park); 2007 Dec; 21(14):1673-81; discussion 1686-8, 1691, 1694. PubMed ID: 18247016
[TBL] [Abstract][Full Text] [Related]
23. Neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: a randomised controlled trial. International collaboration of trialists.
Lancet; 1999 Aug; 354(9178):533-40. PubMed ID: 10470696
[TBL] [Abstract][Full Text] [Related]
24. Adjuvant (post-surgery) chemotherapy for early stage epithelial ovarian cancer.
Winter-Roach BA; Kitchener HC; Dickinson HO
Cochrane Database Syst Rev; 2009 Jan; (1):CD004706. PubMed ID: 19160239
[TBL] [Abstract][Full Text] [Related]
25. Medical interventions for the prevention of platinum-induced hearing loss in children with cancer.
van As JW; van den Berg H; van Dalen EC
Cochrane Database Syst Rev; 2012 May; (5):CD009219. PubMed ID: 22592737
[TBL] [Abstract][Full Text] [Related]
26. Neoadjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis.
Advanced Bladder Cancer Meta-analysis Collaboration
Lancet; 2003 Jun; 361(9373):1927-34. PubMed ID: 12801735
[TBL] [Abstract][Full Text] [Related]
27. Accelerated methotrexate, vinblastine, doxorubicin, and cisplatin (AMVAC) as neoadjuvant chemotherapy for patients with muscle-invasive transitional cell carcinoma of the bladder.
Blick C; Hall P; Pwint T; Al-Terkait F; Crew J; Powles T; Macaulay V; Munro N; Douglas D; Kilbey N; Protheroe A; Chester JD
Cancer; 2012 Aug; 118(16):3920-7. PubMed ID: 22614698
[TBL] [Abstract][Full Text] [Related]
28. Postoperative radiotherapy for non-small cell lung cancer.
PORT Meta-analysis Trialists Group
Cochrane Database Syst Rev; 2005 Apr; (2):CD002142. PubMed ID: 15846628
[TBL] [Abstract][Full Text] [Related]
29. Chemotherapy in advanced ovarian cancer: four systematic meta-analyses of individual patient data from 37 randomized trials. Advanced Ovarian Cancer Trialists' Group.
Aabo K; Adams M; Adnitt P; Alberts DS; Athanazziou A; Barley V; Bell DR; Bianchi U; Bolis G; Brady MF; Brodovsky HS; Bruckner H; Buyse M; Canetta R; Chylak V; Cohen CJ; Colombo N; Conte PF; Crowther D; Edmonson JH; Gennatas C; Gilbey E; Gore M; Guthrie D; Yeap BY
Br J Cancer; 1998 Dec; 78(11):1479-87. PubMed ID: 9836481
[TBL] [Abstract][Full Text] [Related]
30. Five-year followup of a prospective trial of radical cystectomy and neoadjuvant chemotherapy: Nordic Cystectomy Trial I. The Nordic Cooperative Bladder Cancer Study Group.
Malmström PU; Rintala E; Wahlqvist R; Hellström P; Hellsten S; Hannisdal E
J Urol; 1996 Jun; 155(6):1903-6. PubMed ID: 8618283
[TBL] [Abstract][Full Text] [Related]
31. Postoperative radiotherapy for non-small cell lung cancer.
Burdett S; Rydzewska L; Tierney J; Fisher D; Parmar MK; Arriagada R; Pignon JP; Le Pechoux C;
Cochrane Database Syst Rev; 2016 Sep; 9(9):CD002142. PubMed ID: 27684386
[TBL] [Abstract][Full Text] [Related]
32. Squamous Differentiation Predicts Poor Response to Cisplatin-Based Chemotherapy and Unfavorable Prognosis in Urothelial Carcinoma of the Urinary Bladder.
Minato A; Fujimoto N; Kubo T
Clin Genitourin Cancer; 2017 Dec; 15(6):e1063-e1067. PubMed ID: 28803791
[TBL] [Abstract][Full Text] [Related]
33. Neoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and meta-analysis of individual patient data advanced bladder cancer (ABC) meta-analysis collaboration.
Advanced Bladder Cancer (ABC) Meta-analysis Collaboration
Eur Urol; 2005 Aug; 48(2):202-5; discussion 205-6. PubMed ID: 15939524
[TBL] [Abstract][Full Text] [Related]
34. Perioperative chemotherapy in muscle-invasive bladder cancer to enhance survival and/or as a strategy for bladder preservation.
Sternberg CN
Semin Oncol; 2007 Apr; 34(2):122-8. PubMed ID: 17382795
[TBL] [Abstract][Full Text] [Related]
35. Chemotherapy and surgery versus surgery alone in non-small cell lung cancer.
Burdett SS; Stewart LA; Rydzewska L
Cochrane Database Syst Rev; 2007 Jul; (3):CD006157. PubMed ID: 17636828
[TBL] [Abstract][Full Text] [Related]
36. Low incidence of perioperative chemotherapy for stage III bladder cancer 1998 to 2003: a report from the National Cancer Data Base.
David KA; Milowsky MI; Ritchey J; Carroll PR; Nanus DM
J Urol; 2007 Aug; 178(2):451-4. PubMed ID: 17561135
[TBL] [Abstract][Full Text] [Related]
37. Preoperative radiotherapy for esophageal carcinoma.
Arnott SJ; Duncan W; Gignoux M; Hansen HS; Launois B; Nygaard K; Parmar MK; Rousell A; Spilopoulos G; Stewart G; Tierney JF; Wang M; Rhugang Z;
Cochrane Database Syst Rev; 2005 Oct; 2005(4):CD001799. PubMed ID: 16235286
[TBL] [Abstract][Full Text] [Related]
38. Neoadjuvant cisplatinum based combination chemotherapy in patients with invasive bladder cancer: a combined analysis of two Nordic studies.
Sherif A; Holmberg L; Rintala E; Mestad O; Nilsson J; Nilsson S; Malmström PU;
Eur Urol; 2004 Mar; 45(3):297-303. PubMed ID: 15036674
[TBL] [Abstract][Full Text] [Related]
39. [Is there an indication for adjuvant or neoadjuvant systemic chemotherapy in bladder cancer?].
Suttmann H; Retz M; Gschwend JE; Stöckle M
Urologe A; 2007 Oct; 46(10):1379-80, 1382-4. PubMed ID: 17805506
[TBL] [Abstract][Full Text] [Related]
40. Primary cisplatin, methotrexate and vinblastine aiming at bladder preservation in invasive bladder cancer: multivariate analysis on prognostic factors.
Angulo JC; Sanchez-Chapado M; Lopez JI; Flores N
J Urol; 1996 Jun; 155(6):1897-902. PubMed ID: 8618282
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
